View more job listings or post a job
Gilead Sciences, Inc. Senior Research Scientist, Structural Chemistry
Spiral Therapeutics Research Associate, Formulation & Analytical R&D  
SRI International Research Scientist - Bioanalytical Chemistry
Genentech Scientific Researcher/ Senior Scientific Researcher, DMPK
Clovis Oncology Translational Medicine Operations Specialist
RAPT Therapeutics Director Drug Metabolism/Pharmacokinetics
Genentech, Inc. Associate Director/ Director, Drug Discovery Outsourcing
PTC Therapeutics Director, Drug Metabolism and Pharmacokinetics (DMPK)
Frontier Medicines Scientist/Senior Scientist, in vivo pharmacology, Disease Biology
Frontier Medicines Senior R&D Scientific Systems and Software Engineer
Frontier Medicines Scientist / Senior Scientist, Computational Chemistry
Frontier Medicines Director/Associate Director Chemical Biology
Frontier Medicines Principal Scientist/Senior Scientist Biochemistry
Frontier Medicines Principal Scientist Protein Sciences
Frontier Medicines Principal Scientist Chemical Biology
Post a job


[Free Online PBSS-CLSA Symposium] The Drug Discovery and Development Journey of Polivy™ (Polatuzumab Vedotin): An Antibody-Drug Conjugate for the Treatment of Diffuse Large B-cell Lymphoma

Speakers: Andy Polson (Discovery Lead; Principal Scientist), Ola Saad (Bioanalytical; Principal Scientist), Dale Miles (Pharmacology Subteam Lead; Principal Scientist), Donglu Zhang (DMPK; Staff Scientist): ALL from Genentech
Organizers: Cyrus Khojasteh, PhD
Date: 2020-11-13
Time: 11:00-13:00 Pacific Time
Registration fee: (USD):
Location: Online via Zoom
Major Sponsor: (1)Catalent
Vendor show vendors registered to date:
Registration deadline:2020-11-11  (it will close sooner if the seating cap is reached)

About the Topic

This is the inaugural symposium for the "Success Stories of Recently Approved Drugs" series, a collaboration between PBSS - San Francisco Bay and California Life Science Association (CLSA).

Polatuzumab vedotin (POLIVY) is an antibody-drug conjugate (ADC) that contains a humanized immunoglobulin-G1 (IgG1) anti-human CD79b monoclonal antibody and a potent anti‑mitotic agent, monomethyl auristatin E (MMAE), linked through a protease‑cleavable linker, maleimidocaproyl‑valine‑citrulline‑p‑aminobenzyloxycarbonyl (mc‑vc‑PAB). Polatuzumab vedotin has been recently approved in US, Canada, and European Countries to treat B-cell lymphomas. This symposium covers an overview of POLIVY discovery and development which will include its early discovery and clinical readouts, novel clinic pharmacology strategies, and unique regulatory response strategies. The audience will learn about a successful ADC discovery story and embrace the differences between small molecule and ADC drug development.   


11:00 – 11:20 Introduction – Shichang Miao (PBSS), Andrew Satikas (CLSA) and Cyrus Khojasteh (Genentech)

11:20 – 11:40 Discovery and Pharmacology of Polivy - Andy Polson (Genentech)

11:40 – 11:55 Bioanalysis, Biotransformation, and /immunogenicity - Ola Saad (Genentech)

11:55 – 12:05 Major Sponsor Presentation – Catalent

12:05 – 12:35 Clinical Pharmacology - Dale Miles (Genentech)

12:35 – 12:50 Regulatory feedback - Donglu Zhang (Genentech)

12:50 – 1:10 Q&A - All speakers


2020-12-08, [Free Online Symposium - Day 1] Preclinical Models to Guide Therapeutic Development in Oncology
2020-12-15, [Free Online Symposium - Day 2] Preclinical Models to Guide Therapeutic Development in Oncology
2021-07-29, Development of Inhalation Therapeutics (a joint symposium by AAPS-BADG / PBSS / Genentech)
©Pharmaceutical & BioScience Society, International; Last Modified: 12/5/2020; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Gator Bio Gator Bio Next Gen BLI: Label-free system for quantitation, kinetics, and epitope binning. Small molecules, antibodies, biomolecules, receptors.
Eurofins Discovery Biomarker Services Cytokine Storm Assay for immunosafety profiles, STING Assay for in-depth evaluation of immune impacts; 360+ multiparameter flow cytometry capabilities
Eurofins Discovery Phenotypic Services Take a human-centered unbiased approach to drug discovery: Our Phenotypic Center of Excellence features BioMAP®, Biomarker, and OncoPanel™ Services
MaxCyte, Inc High transfection efficiency, cell viability, scale to e10 cells - closed system. R&D thru commercial manuf. for your cell therapy & biologics needs.
Eurofins Discovery On-Demand Take a coffee break with Discovery On-Demand! Mini webinars for remote learning avail 24/7 to accelerate your drug discovery program with confidence.
Hypha Discovery Limited Experts in drug metabolite synthesis & purification including CYP, AOX, FMO metabolites as well as O-, N-, acyl- glucuronides, glycosides & sulfates.
BioPharmEquip Isolators, adherent-cell bioreactors, stability, CCIT + HGA, viable air sampler, -80C biorepository walk-ins, vH202, single-use containment for HPAPIs
Submit a Text Ad